Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1320165
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1320165
Rare Neurological Disease Treatment Market with COVID-19 Impact Analysis, By Drug Class, By Disease Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
PUBLISHED:
PAGES: 356 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Rare Neurological Disease Treatment Market size was valued at USD 9,435.3 Million in 2022, expanding at a CAGR of 7.7% from 2023 to 2030.
The treatment of rare neurological diseases varies depending on the specific condition and its underlying cause. Thus, it becomes essential to consult with a healthcare professional or specialist for treatment of these neurological diseases.
Rare Neurological Disease Treatment Market- Market Dynamics:
Increasing research and development activities is expected to propel the rare neurological disease treatment demand.
Collaboration among researchers, medical professionals, pharmaceutical firms, and patient advocacy organizations has been essential in promoting the creation of medicines for uncommon neurological illnesses. Patient advocacy groups promote research, help, and create awareness, which improves patient outcomes and treatment alternatives. Technology advancements like next-generation sequencing, high-throughput screening, and gene editing methods have sped up the search for and development of viable treatments for uncommon neurological illnesses. Researchers may now identify therapeutic targets, create brand-new medications, and personalize therapy strategies thanks to these technologies.
The biological genetic and molecular developments involved in uncommon neurological illnesses are now better understood because of developments in genomics and molecular biology. This information has created new possibilities for precision medicine and targeted therapeutics.
Rare Neurological Disease Treatment Market- Key Insights:
- As per the analysis shared by our research analyst, the global Rare Neurological Disease Treatment market is estimated to grow annually at a CAGR of around 7.7% over the forecast period (2023-2030)
- The Rare Neurological Disease Treatment industry is projected to grow at a significant rate due to the growing focus on animal health and nutrition.
- Based on Disease Type, Alzheimer's disease segment was predicted to show maximum market share in the year 2022.
- Based on Application, hospital pharmacies segment is expected to hold significant market share by 2030.
- Based on Drug Class segmentation, anti-depressants segment was the leading in 2022
- On the basis of region, North America was the leading revenue generator in 2022.
Rare Neurological Disease Treatment Market- Segmentation Analysis:
The Global Rare Neurological Disease Treatment Market is segmented on the basis of Drug Class, Disease Type, Application, and Region.
The market is divided into five categories based on Drug Class: Anti-depressants, anti-psychotics, cholinesterase inhibitors, biologics, and others. The Anti-depressants segment dominates the market. Growing demand for anti-depressants for disease care is contributing to market growth.
The market is divided into four categories based on Disease Type: Alzheimer's disease, narcolepsy, sclerosis, and others. The Alzheimer's disease segment dominates the market. Growing prevalence of Alzheimer disorders which is influencing the market growth.
The market is divided into three categories based on Application: hospitals & clinics, surgical centers, and others. The hospitals pharmacies segment dominates the market. The rising number of neurological disease treatment at hospital level is increasing the segment growth.
Rare Neurological Disease Treatment Market- Geographical Insights:
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Rare Neurological Disease Treatment Market- Competitive Landscape:
Owing to the rising prevalence of neurological disorders, which influence the rare neurological disease treatment market. Several distribution channels, including corporate websites, and Disease Types, are used by businesses to sell their solutions & products. Products compete on various factors, such as technology, product creation, and marketing. reputation, and availability. Some of the primary techniques, and strategies used by corporations to consolidate their reach and grow their market share include new product launches, R&D expenditure, developing its distribution network and mergers & acquisitions. Some of the recent developments are mentioned below.
Recent Developments:
In 2021, Biogen developed Spinraza (nusinersen), an antisense oligonucleotide, for the treatment of small molecular therapies.
Key features of the study:
- This proposed research study on Rare Neurological Disease Treatment market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
- The report provides the client the latest up-to-date and trending insights about the Rare Neurological Disease Treatment market.
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Rare Neurological Disease Treatment market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Rare Neurological Disease Treatment market
- Impact of COVID-19 on Rare Neurological Disease Treatment market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Rare Neurological Disease Treatment market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the Rare Neurological Disease Treatment market, we have also included competitive landscape and key innovator analysis for the Rare Neurological Disease Treatment market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial in Drug Class and strategic initiatives of players operating in the Rare Neurological Disease Treatment market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global Rare Neurological Disease Treatment market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT MARKET KEY PLAYERS
- Biogen Inc.
- Genzyme Corporation
- Novartis International AG
- Roche Holding AG
- Pfizer Inc.
- Johnson & Johnson
- AbbVie Inc.
- Merck & Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Company Limited
- Alexion Pharmaceuticals, Inc.
- Amgen Inc.
- Vertex Pharmaceuticals Incorporated
- Ionis Pharmaceuticals, Inc.
- Sarepta Therapeutics, Inc.
GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT MARKET, BY DRUG CLASS
- Anti-depressants
- Anti-psychotics
- Cholinesterase inhibitors
- Biologics
- Others
GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT MARKET, BY DISEASE TYPE
- Alzheimer's disease
- Narcolepsy
- Sclerosis
- Others
GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT MARKET, BY APPLICATION
- Hospitals & clinics
- Surgical centers
- Others
GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV1476
Table of Contents
1. Rare Neurological Disease Treatment Market Overview
- 1.1. Study Scope
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Rare Neurological Disease Treatment Market Snippet by Drug Class
- 2.1.2. Rare Neurological Disease Treatment Market Snippet by Disease Type
- 2.1.3. Rare Neurological Disease Treatment Market Snippet by Application
- 2.1.4. Rare Neurological Disease Treatment Market Snippet by Country
- 2.1.5. Rare Neurological Disease Treatment Market Snippet by Region
- 2.2. Competitive Insights
3. Rare Neurological Disease Treatment Key Market Trends
- 3.1. Rare Neurological Disease Treatment Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Rare Neurological Disease Treatment Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Rare Neurological Disease Treatment Market Opportunities
- 3.4. Rare Neurological Disease Treatment Market Future Trends
4. Rare Neurological Disease Treatment Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Rare Neurological Disease Treatment Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Rare Neurological Disease Treatment Market Landscape
- 6.1. Rare Neurological Disease Treatment Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Rare Neurological Disease Treatment Market - By Drug Class
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Drug Class, 2022 & 2030 (%)
- 7.1.2. Anti-depressants
- 7.1.3. Anti-psychotics
- 7.1.4. Cholinesterase inhibitors
- 7.1.5. Biologics
- 7.1.6. Others
8. Rare Neurological Disease Treatment Market - By Disease Type
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Disease Type, 2022 & 2030 (%)
- 8.1.2. Alzheimer's disease
- 8.1.3. Narcolepsy
- 8.1.4. Sclerosis
- 8.1.5. Others
9. Rare Neurological Disease Treatment Market - By Application
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Disease Type, 2022 & 2030 (%)
- 9.1.2. Hospital & clinics
- 9.1.3. Surgical centers
- 9.1.4. Others
10. Rare Neurological Disease Treatment Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Rare Neurological Disease Treatment Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Rare Neurological Disease Treatment Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Rare Neurological Disease Treatment Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Rare Neurological Disease Treatment Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Rare Neurological Disease Treatment Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Rare Neurological Disease Treatment Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Biogen Inc.
- 11.2.2. Genzyme Corporation
- 11.2.3. Novartis International AG
- 11.2.4. Roche Holding AG
- 11.2.5. Pfizer Inc.
- 11.2.6. Johnson & Johnson
- 11.2.7. AbbVie Inc.
- 11.2.8. Merck & Co., Inc.
- 11.2.9. Teva Pharmaceutical Industries Ltd.
- 11.2.10. Takeda Pharmaceutical Company Limited
- 11.2.11. Alexion Pharmaceuticals, Inc.
- 11.2.12. Amgen Inc.
- 11.2.13. Vertex Pharmaceuticals Incorporated
- 11.2.14. Ionis Pharmaceuticals, Inc.
- 11.2.15. Sarepta Therapeutics, Inc.
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
Product Code: ANV1476
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Rare Neurological Disease Treatment Market: Drug Class Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Drug Class
- TABLE Global Rare Neurological Disease Treatment Market, by Drug Class 2018-2030 (USD Million)
- TABLE Rare Neurological Disease Treatment Market: Disease Type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Disease Type
- TABLE Global Rare Neurological Disease Treatment Market, by Disease Type 2018-2030 (USD Million)
- TABLE Rare Neurological Disease Treatment Market: Regional snapshot (2022)
- TABLE Rare Neurological Disease Treatment Market: Application Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Global Rare Neurological Disease Treatment Market, by Application 2018-2030 (USD Million)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Rare Neurological Disease Treatment Market, by Region 2018-2030 (USD Million)
- TABLE North America Rare Neurological Disease Treatment Market, by Country, 2018-2030 (USD Million)
- TABLE North America Rare Neurological Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
- TABLE North America Rare Neurological Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
- TABLE North America Rare Neurological Disease Treatment Market, by Application, 2018-2030 (USD Million)
- TABLE Europe Rare Neurological Disease Treatment Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Rare Neurological Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
- TABLE Europe Rare Neurological Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
- TABLE Europe Rare Neurological Disease Treatment Market, by Application, 2018-2030 (USD Million)
- TABLE Asia Pacific Rare Neurological Disease Treatment Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Rare Neurological Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
- TABLE Asia Pacific Rare Neurological Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
- TABLE Asia Pacific Rare Neurological Disease Treatment Market, by Application, 2018-2030 (USD Million)
- TABLE Latin America Rare Neurological Disease Treatment Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Rare Neurological Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
- TABLE Latin America Rare Neurological Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
- TABLE Latin America Rare Neurological Disease Treatment Market, by Application, 2018-2030 (USD Million)
- TABLE Middle East and Africa Rare Neurological Disease Treatment Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Rare Neurological Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
- TABLE Middle East and Africa Rare Neurological Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
- TABLE Middle East and Africa Rare Neurological Disease Treatment Market, by Application, 2018-2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.